primary hepatic tumor
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
Takeda Sen
University of Yamanashi, Japanese Red Cross Medical Center, The University of Tokyo, Nihon University, Juntendo University, Teikyo University, National Center for Global Health and Medicine, National Cancer Cente Hospitalr
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Those who are diagnosed as primary hepatic tumor by medical doctor (2) Those who agree with the participation to the clinical trial by one's will (3) Those over the age of 20 years old of both sex on the time of acquisition of agreement (4) Those who attend the surgical extirpation of liver (5) Those who have at least one S specimen in the liver (6) Those who are able to provide the contrast enhanced CT
Exclusion criteria
Exclusion criteria: (1) Those who attend the living donor liver transplantation (2) Those with difficulty in specifying or collecting the S specimen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concordance rate of diagnosis by this machine with pathohistological diagnosis on the definitive S specimen | — |
Secondary
| Measure | Time frame |
|---|---|
| Concordance rate of diagnosis by this machine with pathohistological diagnosis on the non S specimen judged by the central committee. Sensitivity, specificity, positive and negative predictive value for the machine diagnosis. | — |
Countries
Japan
Contacts
Public ContactKaneo Satoh
University of Yamanashi Hospital
Outcome results
None listed